Kulicke & Soffa (KLIC) Q2 2026 earnings review
Violent Cyclical Recovery Fueled by Advanced Packaging
The cyclical winter is definitively over for Kulicke & Soffa. Revenue surged 50% YoY to $242.6M in 26Q2, accelerating far beyond expectations. More importantly, 26Q3 guidance projects a staggering $310M in revenue—implying 109% YoY growth as the data center and AI buildouts ignite demand for Thermo-Compression bonding (TCB) and memory assembly. Management is doubling quarterly CapEx to aggressively expand TCB capacity, targeting up to $400M in annual TCB sales. However, this hyper-growth comes at a cost: working capital requirements are draining cash flow, leaving earnings quality temporarily disconnected from cash generation.
🐂 Bull Case
Advanced packaging is moving from narrative to hard revenue. Capex is doubling sequentially to support up to $400M in annual TCB system sales, cementing K&S as a critical infrastructure player in AI and high-bandwidth memory.
Gross margins remained highly resilient at 49.3% in Q2. As revenue scales from the $148M trough to the guided $310M, incremental gross profit will drop aggressively to the bottom line, driving EPS expansion.
🐻 Bear Case
Adjusted free cash flow was anemic at just $6.3M against $42.1M in Non-GAAP Net Income. Rapid scaling is trapping capital in bloated receivables and inventory, starving the company of deployable cash.
Doubling CapEx to force a rapid tripling of Fluxless TCB capacity in Singapore leaves zero room for error. Any supply chain bottlenecks or qualification delays will result in missed orders during this critical cycle phase.
⚖️ Verdict: 🟢
Bullish. The scale and speed of the revenue acceleration override near-term working capital concerns. K&S is successfully transitioning from a legacy wire-bonding provider to an indispensable advanced packaging partner.
Key Themes
Advanced Packaging (TCB) Capacity Surging
Accelerating. The Thermo-Compression bonding (TCB) business is hitting escape velocity. Management announced an immediate near-doubling of CapEx (from $12M to $22M sequentially) specifically to expand TCB production. This investment unlocks capacity for up to $400M in annual TCB system sales—a massive leap from the ~$70M generated in FY25. This confirms K&S is winning significant share in logic and HBM (High-Bandwidth Memory) packaging.
General Semiconductor & Memory Recovery
Accelerating. Driven by the broader data center buildout, core ball bonding and NAND assembly demand is aggressively expanding. Revenue jumped 21% QoQ, proving that utilization rates (which were lingering in the 80% range in prior quarters) have finally triggered the expected wave of major capacity buys.
Working Capital Drain Disconnects Profit from Cash
Reversing. A significant contradiction emerged this quarter: despite reporting $35.1M in GAAP Net Income, Operating Cash Flow was a meager $10.3M. To prepare for Q3's massive revenue guide, Accounts Receivable spiked by $72M (to $255.6M) and Inventories swelled by $46M (to $206.3M) in just one quarter. This massive working capital drain creates liquidity friction during a high-growth phase.
Automotive and Industrial Lag
Stable. While the headline numbers are spectacular, management noted the demand is driven by "technology and capacity needs across general semiconductor, memory, automotive and industrial." However, macro context from prior quarters indicates Auto/Industrial remains the laggard of the group. If global trade tensions or EV adoption continue to stall, this segment could drag down the back half of the cycle.
DRAM Vertical Wire Adoption
Accelerating. Beyond TCB, the company is successfully diversifying its memory exposure away from just NAND. The ATPremier MEM Plus solution (Vertical Wire) for cost-effective DRAM die stacking is expected to transition into high-volume production, providing a secondary growth vector in the memory segment.
Other KPIs
Stable. Despite the rapid 21% QoQ volume ramp, K&S maintained elite gross margins, basically flat vs 26Q1 (49.6%). This indicates strong pricing power, excellent factory absorption, and a highly favorable product mix skewed toward high-end TCB and advanced ball bonders.
Reversing. Barely positive, improving from -$11.6M in 26Q1, but alarmingly low for a company generating $42M in adjusted earnings. Capital expenditures of $4.1M combined with intense working capital buildout severely choked free cash conversion.
Decelerating. The company essentially halted buybacks, repurchasing just 3,000 shares. This is a dramatic drop from prior quarters (e.g., $21.6M in 25Q3, $16.7M in 25Q4) and directly reflects the necessity to preserve cash for the severe working capital demands of the current revenue ramp.
Guidance
Accelerating violently. The midpoint implies a 28% sequential jump and a 109% YoY explosion (vs 25Q3's $148.4M). This shatters typical seasonal patterns and confirms the company has fully entered a major cyclical upswing.
Accelerating. Up from $0.79 in 26Q2. Demonstrates powerful operating leverage as the company guides for Non-GAAP Operating Expenses of $85.0M—keeping expense growth (+16% QoQ) well below revenue growth (+28% QoQ).
Accelerating. The company explicitly stated they are increasing capital investment sequentially from ~$12M to ~$22M to aggressively build out Thermo-Compression bonding (TCB) production.
Key Questions
Working Capital Normalization
Accounts Receivable and Inventories surged by nearly $120 million combined in Q2. At what point in this cyclical recovery do you expect working capital to normalize and cash flow conversion to align with net income?
TCB $400M Capacity Utilization
You are expanding CapEx to support up to $400M in annual TCB sales. Based on current customer engagements, how quickly do you expect to actually utilize that full $400M capacity run-rate?
Gross Margin Trajectory
With revenue guided to cross the $300M threshold in Q3, should we expect gross margins to break decisively above 50% due to volume absorption, or will the costs of scaling TCB production keep them anchored in the high 40s?